ArticleSurgical endoscopy2026
Comparing long-term weight loss and complications in endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a systematic review and meta-analysis.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLaparoscopic sleeve gastrectomy (LSG) is the most common bariatric operation worldwide, with the endoscopic sleeve gastroplasty (ESG) emerging as a non-surgical bariatric procedure with comparable outcomes to LSG. Long-term comparative data of ESG to LSG are limited but increasing. The purpose of this study was to compare the long-term efficacy and adverse outcomes including rates of de novo gastro-esophageal reflux disease (GERD).
methodsA systematic review and meta-analysis were performed comparing outcomes of ESG versus LSG using a random effects model with restricted maximum likelihood. A comprehensive search of Ovid MEDLINE, Ovid Embase, Scopus, Web of Science Core Collection, and Cochrane Library (via Wiley) was performed. Studies comparing outcomes and adverse events following primary ESG or LSG with a sample size > 5 were included.
resultsOf 1136 unique results, 10 studies were included, comprising 7442 patients, of whom 3583 (48%) underwent ESG and 3859 (52%) underwent LSG. Mean age was 35.5 years and mean initial BMI was 34.6 kg/m
conclusionsThe results of this review suggest that while LSG achieves greater weight loss up to two years postoperatively, ESG still displays moderate weight loss with a significantly lower risk of both adverse events and de novo GERD, making it a potential option for patients wishing to avoid greater surgical risks or with pre-existing GERD.
Indexed as
Identifiers
42722912What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.